CJC NO DAC + Ipamorelin 10mg
This blend combines CJC-1295 without DAC (Mod GRF 1-29) with ipamorelin in equal amounts, 5 mg of each. The pair acts on two receptors, GHRH-R and GHS-R1a, so a single preparation can be used to study their combined effect on growth-hormone secretion. Supplied for laboratory research use only. Not for human or veterinary use.
A GHRH analogue and a ghrelin mimetic in one vial, 1:1.
This blend combines CJC-1295 without DAC (Mod GRF 1-29) with ipamorelin in equal amounts, 5 mg of each. The pair acts on two receptors, GHRH-R and GHS-R1a, so a single preparation can be used to study their combined effect on growth-hormone secretion.
What the research shows
Studies of combined GHRH and GHRP administration have examined GH pulse amplitude and frequency, and suggest the two pathways act synergistically rather than simply adding together.
A fixed blend removes the variability of dosing two separate preparations. The published literature reports greater GH release from the combination than from either peptide alone.
Why researchers choose Aevryn Labs
Every batch is tested at a leading Australian university, where HPLC and mass spectrometry confirm a purity of 99% or higher. No generic overseas certificates.
Explore the research library
